世界の椎間板変性症用治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Degenerative Disc Disease Threpeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4104
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、椎間板変性症用治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ALLOB、AMG-0101、BRTX-100、OTICR-01、その他）、用途別市場規模（診療所、病院、ホームケア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・椎間板変性症用治療薬の市場動向
・企業の競争状況、市場シェア
・椎間板変性症用治療薬の種類別市場規模と予測2016-2027（ALLOB、AMG-0101、BRTX-100、OTICR-01、その他）
・椎間板変性症用治療薬の用途別市場規模と予測2016-2027（診療所、病院、ホームケア）
・椎間板変性症用治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・椎間板変性症用治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・椎間板変性症用治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・椎間板変性症用治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・椎間板変性症用治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AnGes MG Inc、Biopharm GmbH、BioRestorative Therapies Inc、Bone Therapeutics SA、DiscGenics Inc、Osiris Therapeutics Inc、Samumed LLC、TissueGene Inc、U.S. Stem Cell Inc、Yuhan Corp）
・結論

Market Analysis and Insights: Global Degenerative Disc Disease Threpeutics Market
The global Degenerative Disc Disease Threpeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Degenerative Disc Disease Threpeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Degenerative Disc Disease Threpeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Degenerative Disc Disease Threpeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Degenerative Disc Disease Threpeutics market.

Global Degenerative Disc Disease Threpeutics Scope and Market Size
Degenerative Disc Disease Threpeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Degenerative Disc Disease Threpeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
ALLOB
AMG-0101
BRTX-100
OTICR-01
Others

Segment by Application
Clinic
Hospital
Homecare

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AnGes MG Inc
Biopharm GmbH
BioRestorative Therapies Inc
Bone Therapeutics SA
DiscGenics Inc
Osiris Therapeutics Inc
Samumed LLC
TissueGene Inc
U.S. Stem Cell Inc
Yuhan Corp

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Degenerative Disc Disease Threpeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 ALLOB
1.2.3 AMG-0101
1.2.4 BRTX-100
1.2.5 OTICR-01
1.2.6 Others
1.3 Market by Application
1.3.1 Global Degenerative Disc Disease Threpeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Homecare
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Degenerative Disc Disease Threpeutics Market Perspective (2016-2027)
2.2 Degenerative Disc Disease Threpeutics Growth Trends by Regions
2.2.1 Degenerative Disc Disease Threpeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Degenerative Disc Disease Threpeutics Historic Market Share by Regions (2016-2021)
2.2.3 Degenerative Disc Disease Threpeutics Forecasted Market Size by Regions (2022-2027)
2.3 Degenerative Disc Disease Threpeutics Industry Dynamic
2.3.1 Degenerative Disc Disease Threpeutics Market Trends
2.3.2 Degenerative Disc Disease Threpeutics Market Drivers
2.3.3 Degenerative Disc Disease Threpeutics Market Challenges
2.3.4 Degenerative Disc Disease Threpeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Degenerative Disc Disease Threpeutics Players by Revenue
3.1.1 Global Top Degenerative Disc Disease Threpeutics Players by Revenue (2016-2021)
3.1.2 Global Degenerative Disc Disease Threpeutics Revenue Market Share by Players (2016-2021)
3.2 Global Degenerative Disc Disease Threpeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Degenerative Disc Disease Threpeutics Revenue
3.4 Global Degenerative Disc Disease Threpeutics Market Concentration Ratio
3.4.1 Global Degenerative Disc Disease Threpeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Degenerative Disc Disease Threpeutics Revenue in 2020
3.5 Degenerative Disc Disease Threpeutics Key Players Head office and Area Served
3.6 Key Players Degenerative Disc Disease Threpeutics Product Solution and Service
3.7 Date of Enter into Degenerative Disc Disease Threpeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Degenerative Disc Disease Threpeutics Breakdown Data by Type
4.1 Global Degenerative Disc Disease Threpeutics Historic Market Size by Type (2016-2021)
4.2 Global Degenerative Disc Disease Threpeutics Forecasted Market Size by Type (2022-2027)

5 Degenerative Disc Disease Threpeutics Breakdown Data by Application
5.1 Global Degenerative Disc Disease Threpeutics Historic Market Size by Application (2016-2021)
5.2 Global Degenerative Disc Disease Threpeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Degenerative Disc Disease Threpeutics Market Size (2016-2027)
6.2 North America Degenerative Disc Disease Threpeutics Market Size by Type
6.2.1 North America Degenerative Disc Disease Threpeutics Market Size by Type (2016-2021)
6.2.2 North America Degenerative Disc Disease Threpeutics Market Size by Type (2022-2027)
6.2.3 North America Degenerative Disc Disease Threpeutics Market Size by Type (2016-2027)
6.3 North America Degenerative Disc Disease Threpeutics Market Size by Application
6.3.1 North America Degenerative Disc Disease Threpeutics Market Size by Application (2016-2021)
6.3.2 North America Degenerative Disc Disease Threpeutics Market Size by Application (2022-2027)
6.3.3 North America Degenerative Disc Disease Threpeutics Market Size by Application (2016-2027)
6.4 North America Degenerative Disc Disease Threpeutics Market Size by Country
6.4.1 North America Degenerative Disc Disease Threpeutics Market Size by Country (2016-2021)
6.4.2 North America Degenerative Disc Disease Threpeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Degenerative Disc Disease Threpeutics Market Size (2016-2027)
7.2 Europe Degenerative Disc Disease Threpeutics Market Size by Type
7.2.1 Europe Degenerative Disc Disease Threpeutics Market Size by Type (2016-2021)
7.2.2 Europe Degenerative Disc Disease Threpeutics Market Size by Type (2022-2027)
7.2.3 Europe Degenerative Disc Disease Threpeutics Market Size by Type (2016-2027)
7.3 Europe Degenerative Disc Disease Threpeutics Market Size by Application
7.3.1 Europe Degenerative Disc Disease Threpeutics Market Size by Application (2016-2021)
7.3.2 Europe Degenerative Disc Disease Threpeutics Market Size by Application (2022-2027)
7.3.3 Europe Degenerative Disc Disease Threpeutics Market Size by Application (2016-2027)
7.4 Europe Degenerative Disc Disease Threpeutics Market Size by Country
7.4.1 Europe Degenerative Disc Disease Threpeutics Market Size by Country (2016-2021)
7.4.2 Europe Degenerative Disc Disease Threpeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Degenerative Disc Disease Threpeutics Market Size (2016-2027)
8.2 Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Type
8.2.1 Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Application
8.3.1 Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Region
8.4.1 Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Degenerative Disc Disease Threpeutics Market Size (2016-2027)
9.2 Latin America Degenerative Disc Disease Threpeutics Market Size by Type
9.2.1 Latin America Degenerative Disc Disease Threpeutics Market Size by Type (2016-2021)
9.2.2 Latin America Degenerative Disc Disease Threpeutics Market Size by Type (2022-2027)
9.2.3 Latin America Degenerative Disc Disease Threpeutics Market Size by Type (2016-2027)
9.3 Latin America Degenerative Disc Disease Threpeutics Market Size by Application
9.3.1 Latin America Degenerative Disc Disease Threpeutics Market Size by Application (2016-2021)
9.3.2 Latin America Degenerative Disc Disease Threpeutics Market Size by Application (2022-2027)
9.3.3 Latin America Degenerative Disc Disease Threpeutics Market Size by Application (2016-2027)
9.4 Latin America Degenerative Disc Disease Threpeutics Market Size by Country
9.4.1 Latin America Degenerative Disc Disease Threpeutics Market Size by Country (2016-2021)
9.4.2 Latin America Degenerative Disc Disease Threpeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Degenerative Disc Disease Threpeutics Market Size (2016-2027)
10.2 Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Type
10.2.1 Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Application
10.3.1 Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Country
10.4.1 Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AnGes MG Inc
11.1.1 AnGes MG Inc Company Details
11.1.2 AnGes MG Inc Business Overview
11.1.3 AnGes MG Inc Degenerative Disc Disease Threpeutics Introduction
11.1.4 AnGes MG Inc Revenue in Degenerative Disc Disease Threpeutics Business (2016-2021)
11.1.5 AnGes MG Inc Recent Development
11.2 Biopharm GmbH
11.2.1 Biopharm GmbH Company Details
11.2.2 Biopharm GmbH Business Overview
11.2.3 Biopharm GmbH Degenerative Disc Disease Threpeutics Introduction
11.2.4 Biopharm GmbH Revenue in Degenerative Disc Disease Threpeutics Business (2016-2021)
11.2.5 Biopharm GmbH Recent Development
11.3 BioRestorative Therapies Inc
11.3.1 BioRestorative Therapies Inc Company Details
11.3.2 BioRestorative Therapies Inc Business Overview
11.3.3 BioRestorative Therapies Inc Degenerative Disc Disease Threpeutics Introduction
11.3.4 BioRestorative Therapies Inc Revenue in Degenerative Disc Disease Threpeutics Business (2016-2021)
11.3.5 BioRestorative Therapies Inc Recent Development
11.4 Bone Therapeutics SA
11.4.1 Bone Therapeutics SA Company Details
11.4.2 Bone Therapeutics SA Business Overview
11.4.3 Bone Therapeutics SA Degenerative Disc Disease Threpeutics Introduction
11.4.4 Bone Therapeutics SA Revenue in Degenerative Disc Disease Threpeutics Business (2016-2021)
11.4.5 Bone Therapeutics SA Recent Development
11.5 DiscGenics Inc
11.5.1 DiscGenics Inc Company Details
11.5.2 DiscGenics Inc Business Overview
11.5.3 DiscGenics Inc Degenerative Disc Disease Threpeutics Introduction
11.5.4 DiscGenics Inc Revenue in Degenerative Disc Disease Threpeutics Business (2016-2021)
11.5.5 DiscGenics Inc Recent Development
11.6 Osiris Therapeutics Inc
11.6.1 Osiris Therapeutics Inc Company Details
11.6.2 Osiris Therapeutics Inc Business Overview
11.6.3 Osiris Therapeutics Inc Degenerative Disc Disease Threpeutics Introduction
11.6.4 Osiris Therapeutics Inc Revenue in Degenerative Disc Disease Threpeutics Business (2016-2021)
11.6.5 Osiris Therapeutics Inc Recent Development
11.7 Samumed LLC
11.7.1 Samumed LLC Company Details
11.7.2 Samumed LLC Business Overview
11.7.3 Samumed LLC Degenerative Disc Disease Threpeutics Introduction
11.7.4 Samumed LLC Revenue in Degenerative Disc Disease Threpeutics Business (2016-2021)
11.7.5 Samumed LLC Recent Development
11.8 TissueGene Inc
11.8.1 TissueGene Inc Company Details
11.8.2 TissueGene Inc Business Overview
11.8.3 TissueGene Inc Degenerative Disc Disease Threpeutics Introduction
11.8.4 TissueGene Inc Revenue in Degenerative Disc Disease Threpeutics Business (2016-2021)
11.8.5 TissueGene Inc Recent Development
11.9 U.S. Stem Cell Inc
11.9.1 U.S. Stem Cell Inc Company Details
11.9.2 U.S. Stem Cell Inc Business Overview
11.9.3 U.S. Stem Cell Inc Degenerative Disc Disease Threpeutics Introduction
11.9.4 U.S. Stem Cell Inc Revenue in Degenerative Disc Disease Threpeutics Business (2016-2021)
11.9.5 U.S. Stem Cell Inc Recent Development
11.10 Yuhan Corp
11.10.1 Yuhan Corp Company Details
11.10.2 Yuhan Corp Business Overview
11.10.3 Yuhan Corp Degenerative Disc Disease Threpeutics Introduction
11.10.4 Yuhan Corp Revenue in Degenerative Disc Disease Threpeutics Business (2016-2021)
11.10.5 Yuhan Corp Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Degenerative Disc Disease Threpeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of ALLOB
Table 3. Key Players of AMG-0101
Table 4. Key Players of BRTX-100
Table 5. Key Players of OTICR-01
Table 6. Key Players of Others
Table 7. Global Degenerative Disc Disease Threpeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Degenerative Disc Disease Threpeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Degenerative Disc Disease Threpeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Degenerative Disc Disease Threpeutics Market Share by Regions (2016-2021)
Table 11. Global Degenerative Disc Disease Threpeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Degenerative Disc Disease Threpeutics Market Share by Regions (2022-2027)
Table 13. Degenerative Disc Disease Threpeutics Market Trends
Table 14. Degenerative Disc Disease Threpeutics Market Drivers
Table 15. Degenerative Disc Disease Threpeutics Market Challenges
Table 16. Degenerative Disc Disease Threpeutics Market Restraints
Table 17. Global Degenerative Disc Disease Threpeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Degenerative Disc Disease Threpeutics Market Share by Players (2016-2021)
Table 19. Global Top Degenerative Disc Disease Threpeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Degenerative Disc Disease Threpeutics as of 2020)
Table 20. Ranking of Global Top Degenerative Disc Disease Threpeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Degenerative Disc Disease Threpeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Degenerative Disc Disease Threpeutics Product Solution and Service
Table 24. Date of Enter into Degenerative Disc Disease Threpeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Degenerative Disc Disease Threpeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Degenerative Disc Disease Threpeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Degenerative Disc Disease Threpeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Degenerative Disc Disease Threpeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Degenerative Disc Disease Threpeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Degenerative Disc Disease Threpeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Degenerative Disc Disease Threpeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Degenerative Disc Disease Threpeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Degenerative Disc Disease Threpeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Degenerative Disc Disease Threpeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Degenerative Disc Disease Threpeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Degenerative Disc Disease Threpeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Degenerative Disc Disease Threpeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Degenerative Disc Disease Threpeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Degenerative Disc Disease Threpeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Degenerative Disc Disease Threpeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Degenerative Disc Disease Threpeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Degenerative Disc Disease Threpeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Degenerative Disc Disease Threpeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Degenerative Disc Disease Threpeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Degenerative Disc Disease Threpeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Degenerative Disc Disease Threpeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Degenerative Disc Disease Threpeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Degenerative Disc Disease Threpeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Degenerative Disc Disease Threpeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Degenerative Disc Disease Threpeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. AnGes MG Inc Company Details
Table 65. AnGes MG Inc Business Overview
Table 66. AnGes MG Inc Degenerative Disc Disease Threpeutics Product
Table 67. AnGes MG Inc Revenue in Degenerative Disc Disease Threpeutics Business (2016-2021) & (US$ Million)
Table 68. AnGes MG Inc Recent Development
Table 69. Biopharm GmbH Company Details
Table 70. Biopharm GmbH Business Overview
Table 71. Biopharm GmbH Degenerative Disc Disease Threpeutics Product
Table 72. Biopharm GmbH Revenue in Degenerative Disc Disease Threpeutics Business (2016-2021) & (US$ Million)
Table 73. Biopharm GmbH Recent Development
Table 74. BioRestorative Therapies Inc Company Details
Table 75. BioRestorative Therapies Inc Business Overview
Table 76. BioRestorative Therapies Inc Degenerative Disc Disease Threpeutics Product
Table 77. BioRestorative Therapies Inc Revenue in Degenerative Disc Disease Threpeutics Business (2016-2021) & (US$ Million)
Table 78. BioRestorative Therapies Inc Recent Development
Table 79. Bone Therapeutics SA Company Details
Table 80. Bone Therapeutics SA Business Overview
Table 81. Bone Therapeutics SA Degenerative Disc Disease Threpeutics Product
Table 82. Bone Therapeutics SA Revenue in Degenerative Disc Disease Threpeutics Business (2016-2021) & (US$ Million)
Table 83. Bone Therapeutics SA Recent Development
Table 84. DiscGenics Inc Company Details
Table 85. DiscGenics Inc Business Overview
Table 86. DiscGenics Inc Degenerative Disc Disease Threpeutics Product
Table 87. DiscGenics Inc Revenue in Degenerative Disc Disease Threpeutics Business (2016-2021) & (US$ Million)
Table 88. DiscGenics Inc Recent Development
Table 89. Osiris Therapeutics Inc Company Details
Table 90. Osiris Therapeutics Inc Business Overview
Table 91. Osiris Therapeutics Inc Degenerative Disc Disease Threpeutics Product
Table 92. Osiris Therapeutics Inc Revenue in Degenerative Disc Disease Threpeutics Business (2016-2021) & (US$ Million)
Table 93. Osiris Therapeutics Inc Recent Development
Table 94. Samumed LLC Company Details
Table 95. Samumed LLC Business Overview
Table 96. Samumed LLC Degenerative Disc Disease Threpeutics Product
Table 97. Samumed LLC Revenue in Degenerative Disc Disease Threpeutics Business (2016-2021) & (US$ Million)
Table 98. Samumed LLC Recent Development
Table 99. TissueGene Inc Company Details
Table 100. TissueGene Inc Business Overview
Table 101. TissueGene Inc Revenue in Degenerative Disc Disease Threpeutics Business (2016-2021) & (US$ Million)
Table 102. TissueGene Inc Recent Development
Table 103. U.S. Stem Cell Inc Company Details
Table 104. U.S. Stem Cell Inc Business Overview
Table 105. U.S. Stem Cell Inc Degenerative Disc Disease Threpeutics Product
Table 106. U.S. Stem Cell Inc Revenue in Degenerative Disc Disease Threpeutics Business (2016-2021) & (US$ Million)
Table 107. U.S. Stem Cell Inc Recent Development
Table 108. Yuhan Corp Company Details
Table 109. Yuhan Corp Business Overview
Table 110. Yuhan Corp Degenerative Disc Disease Threpeutics Product
Table 111. Yuhan Corp Revenue in Degenerative Disc Disease Threpeutics Business (2016-2021) & (US$ Million)
Table 112. Yuhan Corp Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Degenerative Disc Disease Threpeutics Market Share by Type: 2020 VS 2027
Figure 2. ALLOB Features
Figure 3. AMG-0101 Features
Figure 4. BRTX-100 Features
Figure 5. OTICR-01 Features
Figure 6. Others Features
Figure 7. Global Degenerative Disc Disease Threpeutics Market Share by Application: 2020 VS 2027
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Homecare Case Studies
Figure 11. Degenerative Disc Disease Threpeutics Report Years Considered
Figure 12. Global Degenerative Disc Disease Threpeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Degenerative Disc Disease Threpeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Degenerative Disc Disease Threpeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Degenerative Disc Disease Threpeutics Market Share by Regions (2022-2027)
Figure 16. Global Degenerative Disc Disease Threpeutics Market Share by Players in 2020
Figure 17. Global Top Degenerative Disc Disease Threpeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Degenerative Disc Disease Threpeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Degenerative Disc Disease Threpeutics Revenue in 2020
Figure 19. Global Degenerative Disc Disease Threpeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Degenerative Disc Disease Threpeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Degenerative Disc Disease Threpeutics Market Share by Type (2016-2027)
Figure 23. North America Degenerative Disc Disease Threpeutics Market Share by Application (2016-2027)
Figure 24. North America Degenerative Disc Disease Threpeutics Market Share by Country (2016-2027)
Figure 25. United States Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Degenerative Disc Disease Threpeutics Market Share by Type (2016-2027)
Figure 29. Europe Degenerative Disc Disease Threpeutics Market Share by Application (2016-2027)
Figure 30. Europe Degenerative Disc Disease Threpeutics Market Share by Country (2016-2027)
Figure 31. Germany Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Degenerative Disc Disease Threpeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Degenerative Disc Disease Threpeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Degenerative Disc Disease Threpeutics Market Share by Region (2016-2027)
Figure 41. China Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Degenerative Disc Disease Threpeutics Market Share by Type (2016-2027)
Figure 49. Latin America Degenerative Disc Disease Threpeutics Market Share by Application (2016-2027)
Figure 50. Latin America Degenerative Disc Disease Threpeutics Market Share by Country (2016-2027)
Figure 51. Mexico Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Degenerative Disc Disease Threpeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Degenerative Disc Disease Threpeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Degenerative Disc Disease Threpeutics Market Share by Country (2016-2027)
Figure 57. Turkey Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Degenerative Disc Disease Threpeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. AnGes MG Inc Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2016-2021)
Figure 61. Biopharm GmbH Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2016-2021)
Figure 62. BioRestorative Therapies Inc Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2016-2021)
Figure 63. Bone Therapeutics SA Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2016-2021)
Figure 64. DiscGenics Inc Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2016-2021)
Figure 65. Osiris Therapeutics Inc Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2016-2021)
Figure 66. Samumed LLC Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2016-2021)
Figure 67. TissueGene Inc Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2016-2021)
Figure 68. U.S. Stem Cell Inc Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2016-2021)
Figure 69. Yuhan Corp Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界の人工椎間板核市場規模・現状・予測（2021年-2027年）

Global Prosthetic Disc Nucleus Market Size, Status and Forecast 2021-2027
QFJ1-5318 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、人工椎間板核の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（低侵襲脊椎手術、開放脊椎手術）、用途別市場規模（病院、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年）

Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5033 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、フォン・ヴィレブランド病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Veyvondi、Humate-P、Alphanate、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模...

世界のペイロニー病治療市場規模・現状・予測（2021年-2027年）

Global Peyronie’s Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4696 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、ペイロニー病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、手術）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のゴーシェ病（GD）治療薬市場規模・現状・予測（2021年-2027年）

Global Gaucher Disease (GD) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5747 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ゴーシェ病（GD）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（酵素補充療法、基質減少療法）、用途別市場規模（非神経障害性ゴーシェ病、神経障害性ゴーシェ病）、主要地域別市場規模（北米、アメリカ...

世界のバッテン病治療市場規模・現状・予測（2021年-2027年）

Global Batten Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3891 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、バッテン病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（作業療法、理学療法）、用途別市場規模（乳児NCL、後期乳児NCL、少年NCL、成人NCL）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の網膜疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Retinal Disease Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4825 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、網膜疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（黄斑変性症、糖尿病性黄斑浮腫、糖尿病性網膜症、網膜静脈閉塞症）、用途別市場規模（病院薬局、小売薬局、その他）、主要地域別市場規模（北米、ア...

世界のバセドウ病市場規模・現状・予測（2021年-2027年）

Global Graves Disease Market Size, Status and Forecast 2021-2027
QFJ1-4273 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、バセドウ病の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗甲状腺剤、ロジン＆ロディド、放射性ロジン、ロニック阻害剤）、用途別市場規模（病院薬局、オンライン薬局、小売店薬局）、主要地域別市場規模（北米...

世界のメニエール病治療薬パイプライン市場規模・現状・予測（2021年-2027年）

Global Meniere Disease Drug Pipeline Market Size, Status and Forecast 2021-2027
QFJ1-4490 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、メニエール病治療薬パイプラインの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（めまい、耳分泌物、その他）、用途別市場規模（病院・クリニック、専門センター）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界のアジソン病用治療市場規模・現状・予測（2021年-2027年）

Global Addison's Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3763 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、アジソン病用治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口コルチコステロイド、コルチコステロイド注射）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の性感染症（STD）検査市場規模・現状・予測（2021年-2027年）

Global Sexually Transmitted Disease (STD) Testing Market Size, Status and Forecast 2021-2027
QFJ1-4856 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、性感染症（STD）検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（実験室試験装置、POC試験装置）、用途別市場規模（病院、研究機関、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界のディスクブレーキシステム市場規模・現状・予測（2021年-2027年） A disc brake is a type of brake that uses calipers to squeeze pairs of pads against a disc or "rotor" to create friction. Market Analysis and Insights: Global Disc Brake Systems Market The global Disc Brake Systems market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020…
世界の人工椎間板核市場規模・現状・予測（2021年-2027年） Due to the sedentary lifestyle of modern people and lack of exercise, the probability of spine problems is greatly increased. The arrival of nucleus pulposus (NP) replacement has emerged as an ideal minimally invasive alternative to discectomy with fusion, and it plays a key role in preventing adjac…
ブレイドディスクのグローバル市場2021 Disc Blades are a farm implement that is used to till the soil where crops are to be planted. It is also used to chop up unwanted weeds or crop remainders. Usually Disc Blades consists of carbon steel. Market Analysis and Insights: Global Disc Blades Market The global Disc Blades market was valued a…
研磨ディスクのグローバル市場2021 Abrasive disc is a coated abrasive which bonded fine ore abrasive grains to the base material of uniform thickness. It can machine a uniform surface. Abrasive discs consist of abrasive grains adhered onto a backing of cloth, fiber, film, paper, non-woven, or other material. These units are then moun…
世界の人工椎間板置換システム市場規模・現状・予測（2021年-2027年） Artificial Disc Replacement Systems offers an alternative to spinal fusion for the patients who have chronic back pain from degenerative disc disease. It allows natural motion in the part of the spine where the disc is implanted and thus allows for an early return to function. Market Analysis and In…